112 results on '"Klar, Richard"'
Search Results
2. Strong single-agent and PD-1/PD-L1 combination antitumor activity of antisense oligonucleotides suppressing Neuropilin 1 expression.
3. Characterization of the TLR9-Activating Potential of LNA-Modified Antisense Oligonucleotides.
4. Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines
5. A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression
6. Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro
7. 881 Knockdown of neuropilin-1 by third generation antisense oligonucleotides has strong antitumor activity that can be further increased by combination with immune checkpoint inhibitors
8. Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice
9. Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity
10. Supplementary Information from Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis
11. Supplementary Material and Methods from Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis
12. Data from Immuno-PET Imaging of Engineered Human T Cells in Tumors
13. Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity
14. Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
15. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
16. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
17. 434 Targeting the expression of Neuropilin-1 by locked nucleic acid modified antisense oligonucleotides results in potent anti-tumor activity in vivo
18. Abstract 4149: Knock-down of Neuropilin-1 by locked nucleic acid antisense oligonucleotides facilitates cancer immune control
19. Investigation of the Activity of Antisense Oligonucleotides Targeting Multiple Genes by RNA-Sequencing
20. CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease
21. The United States Supreme Court's decision in eBay v. MercExchange: how irreparable the injury to patent injunctions?
22. Ebay Inc. v. Mercexchange, L.L.C.: the right to exclude under United States patent law and the public interest.
23. Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis
24. Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines
25. Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity
26. Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation
27. A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression
28. Additional file 5: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
29. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
30. Additional file 4: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
31. Additional file 2: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
32. Additional file 3: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
33. Additional file 1: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
34. Ebay Inc. v. Mercexchange, L.L.C.: the right to exclude under U.S. patent law and the public interest.
35. Abstract 5021: LNAplusTMantisense oligonucleotides targeting CD39 and CD73 have potent anti-tumor activity by modulating immunosuppressive tumor microenvironment
36. Abstract 3275: Inhibition of ER-stress factor C/EBP homologous protein (Chop) with LNAplus™ antisense-oligonucleotides to improve immunotherapy of cancer
37. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
38. Three-dimensional electrical resistivity for detection of subsurface karst associated with Friesenhahn Cave
39. Identification of naturally presented HLA ligands on the surface of healthy and malignant hematopoetic cells and their therapeutic potential as targets for TCR-transgenic T cells
40. Abstract 5909: Inhibition of Cd39 and Cd73 by 3rd-generation antisense oligonucleotides to improve immunity against tumors
41. Identification of naturally presented HLA ligands on the surface of healthy and malignant hematopoetic cells and their therapeutic potential as targets for TCR-transgenic T cells
42. Identification of naturally presented HLA ligands on the surface of healthy and malignant hematopoetic cells and their therapeutic potential as targets for TCR-transgenic T cells
43. In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET
44. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
45. Abstract 3202: Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity
46. Immuno-PET Imaging of Engineered Human T Cells in Tumors
47. Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo
48. Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity
49. ITOC2 – 021. The melanoma immune-peptidome for T-cell-based anti-tumour immunotherapies
50. Kawasaki Disease Lacks Association With Human Coronavirus NL63 and Human Bocavirus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.